Predictors of hepatorenal syndrome in alcoholic liver cirrhosis

被引:11
|
作者
Janicko, Martin [1 ]
Veseliny, Eduard [1 ]
Senajova, Gabriela [1 ]
Jarcuska, Peter [1 ]
机构
[1] Safarik Univ, Univ Hosp, Dept Internal Med 1, Kosice, Slovakia
来源
BIOMEDICAL PAPERS-OLOMOUC | 2015年 / 159卷 / 04期
关键词
alcohol; liver cirrhosis; hepatorenal syndrome; predictors; SPONTANEOUS BACTERIAL PERITONITIS; RENAL IMPAIRMENT; PROGNOSIS; ASCITES; HYPONATREMIA; MORTALITY; SURVIVAL; IMPROVES; DISEASE;
D O I
10.5507/bp.2015.010
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Background. Alcoholic liver disease is a major cause of liver cirrhosis and the hepatorenal syndrome is a serious complication. Risk factors for hepatorenal syndrome (HRS) in alcoholic liver cirrhosis are not entirely explored. Aim. To assess the risk factors for hepatorenal syndrome in alcoholic liver cirrhosis. Patients and Methods. Consecutive patients with alcoholic liver disease were followed for two months, development of renal failure, classified either as HRS or renal failure not fulfilling criteria of HRS, was the main outcome. Results. Of 171 patients, 14 (8.2%) developed HRS and 13 (7.6%), renal failure not fulfilling the HRS criteria. A significant difference was found between patients with and without HRS in serum sodium (131.1 +/- 3.8 vs. 135.7 +/- 5.2; P = 0.003), creatinine, (94.1 +/- 26.8 vs. 80.3 +/- 20.2; P < 0.001), albumin (23.5 +/- 4.9 vs. 29.9 +/- 5.8; P < 0.001), INR (1.76 +/- 0.45 vs. 1.44 +/- 0.41; P < 0.001), bilirubin (252.3 +/- 179.4 vs. 91.2 +/- 101.0; P < 0.001), MELD (23 +/- 6 vs 15 +/- 5; P < 0.001) and MELD-Na score (27 +/- 5 vs. 18 +/- 6; P < 0.001). Multivariate analysis adjusted for sex and age showed that sodium together with creatinine are the strongest HRS predictors, followed by bilirubin with respective odds' ratios (95% CI) of 1.041 (1.012-1.072) for creatinine, 0.870 (0.766-0.988) for serum sodium and 1.005 (1.001-1.010) for serum bilirubin. Conclusion. Serum levels of sodium, creatinine and bilirubin are important predictors of the hepatorenal syndrome.
引用
收藏
页码:661 / 665
页数:5
相关论文
共 50 条
  • [1] Deranged Biochemical Markers As Early Predictors for the Development of Hepatorenal Syndrome in Patients With Alcoholic Liver Cirrhosis
    Deorukhkar, Durga
    Sonawale, Archana
    Goyal, Aman
    Sonawale, Kshitij
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
  • [2] Diagnostical significance of dimethylarginine in the development of hepatorenal syndrome in patients with alcoholic liver cirrhosis
    Nickovic, Vanja
    Nikolic, Jelenka
    Djindjic, Natasa
    Ilic, Milena
    Nickovic, Jovan
    Mladenovic, Dragan
    Krstic, Nebojsa
    VOJNOSANITETSKI PREGLED, 2012, 69 (08) : 686 - 691
  • [3] Cystatin C: a predictor of hepatorenal syndrome in patients with liver cirrhosis
    Sharawey, Mohammed A.
    Shawky, Eglal M.
    Ali, Lamia H.
    Mohammed, Ahmed Ali
    Hassan, Hatem A.
    Fouad, Yasser M.
    HEPATOLOGY INTERNATIONAL, 2011, 5 (04) : 927 - 933
  • [4] VASOPRESSOR THERAPY OF HEPATORENAL SYNDROME AGAINST THE BACKGROUND OF ALCOHOLIC LIVER CIRRHOSIS
    Slyvka, N. O.
    Lukashiv, T. O.
    Rusnak, I. T.
    Sydorchuk, A. S.
    Al Salama, M. V. O.
    Rovinskyi, O. O.
    Akentiev, S. O.
    WORLD OF MEDICINE AND BIOLOGY, 2021, 77 (03): : 158 - 162
  • [5] Serum Sodium Identifies Patients with Cirrhosis at High Risk of Hepatorenal Syndrome
    Janicko, M.
    Veseliny, E.
    Abraldes, J. G.
    Jarcuska, P.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2013, 51 (07): : 628 - 634
  • [6] Acute kidney injury and hepatorenal syndrome in cirrhosis
    Gupta, Kapil
    Bhurwal, Abhishek
    Law, Cindy
    Ventre, Scott
    Minacapelli, Carlos D.
    Kabaria, Savan
    Li, You
    Tait, Christopher
    Catalano, Carolyn
    Rustgi, Vinod K.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (26) : 3984 - 4003
  • [7] Complications of liver cirrhosis . Ascites, spontaneous bacterial peritonitis and hepatorenal syndrome
    Guelberg, V.
    Gerbes, A. L.
    GASTROENTEROLOGE, 2013, 8 (03): : 241 - 247
  • [8] Alcoholic cirrhosis-associated hepatorenal syndrome treated with vasoactive agents
    Esrailian, E
    Runyon, BA
    NATURE CLINICAL PRACTICE NEPHROLOGY, 2006, 2 (03): : 169 - 172
  • [9] Safety of Nonselective Beta-Blockers in Decompensated Liver Cirrhosis and Their Role in Inducing Hepatorenal Syndrome
    Qaqish, Faris
    Dimachkie, Reem
    Sasso, Roula
    Loeffler, Jeffrey
    Hasan, Mohammed
    Deghani, Shabnam
    Yassine, Ahmad Abou
    Deeb, Liliane
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
  • [10] Vasoconstrictor therapy for hepatorenal syndrome in liver cirrhosis
    Schmidt, L. E.
    Ring-Larsen, H.
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (35) : 4637 - 4647